Tenofovir: Q&A for Patients and Providers
<p>Scientists at the San Francisco VA Medical Center and the University of California, San Francisco have published a study showing that one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, tenofovir, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time. See accompanying news release, <a href="http://ucsf.edu/news/2012/02/11508/tenofovir-leading-hiv-medication-linked-risk-kidney-damage">Tenofovir, Leading HIV Medication, Linked with Risk of Kidney Damage</a>.</p>